Impact of the Spread of COVID-19 on Business Activity and Earnings
First written in FY2020-Q2. 6 of 18 entries say "Worsened", first in FY2021-Q1. Latest entry: FY2025.
Leoclan moved to the "Worse" side of this theme in 2020, 6 years before the typical company in this theme (2026).
0 other companies' latest entry also says "Dropped".
- FY2025DroppedAnnual report
「The medical industry in which the Group operates continues to face a challenging operating environment for medical institutions because of soaring prices and other factors.」
In the filing's descriptions of business and other risks and the business environment, the impact of COVID-19 on business activities and earnings is not identified as a standalone risk. The focus of the medical institutions' operating environment has shifted to soaring prices, healthcare system reform and labor shortages. - FY2025-H1RestatedAnnual report
「During the interim consolidated accounting period, there were no new occurrences of major risks that management recognizes could materially affect the financial position, operating results or cash flows of the consolidated companies among the matters concerning business conditions and financial matters described in this interim report, nor any material changes to the “Business and Other Risks” described in the annual securities report for the previous fiscal year.」
The Group concluded that there had been no material change in the risk of the COVID-19 pandemic affecting business activities and earnings. - FY2024SoftenedAnnual report
「During the current consolidated fiscal year, socioeconomic activity continued to normalize and the economy remained on a gradual recovery trend.」
Perceptions of a direct deterioration in business activity caused by the spread of the infectious disease receded, and normalization of socioeconomic activity was indicated. Meanwhile, uncertainty arising from unstable international conditions, inflation and exchange-rate fluctuations continues. - FY2024-Q2RestatedAnnual report
「During the second quarter of the current consolidated cumulative period, socioeconomic activity had been recovering gradually as restrictions on activity were eased, but uncertainty about the outlook continued amid unstable international conditions, a substantial depreciation of the yen and rising prices driven by soaring global resource prices.」
While restrictions on activity continued to ease and socioeconomic activity recovered, uncertainty surrounding the post-pandemic business environment persisted because of international conditions, the weaker yen and soaring resource prices. - FY2024-Q1SoftenedAnnual report
「During the first quarter of the current consolidated cumulative period, socioeconomic activity had been recovering gradually as restrictions on activity were eased, but uncertainty about the outlook continued amid unstable conditions overseas, a rapid depreciation of the yen and rising prices driven by soaring global resource prices.」
The easing of restrictions on activity and gradual recovery of socioeconomic activity were indicated, weakening perceptions of a direct deterioration in the business environment caused by the infectious disease. Meanwhile, uncertainty arising from unstable conditions overseas, the weaker yen and soaring resource prices continues. - FY2023SoftenedAnnual report
「During the current consolidated fiscal year, Japan's economy was in an uncertain environment. Socioeconomic activity had been recovering gradually following the reclassification of COVID-19 to Category V under the Infectious Diseases Control Law, but energy and raw material prices were rising because of the Russia-Ukraine situation and the prolonged depreciation of the yen, leading to further price increases.」
The reclassification of COVID-19 to Category V under the Infectious Diseases Control Law and the gradual recovery of socioeconomic activity were indicated, weakening perceptions of a direct deterioration in the business environment caused by the infectious disease. Meanwhile, uncertainty surrounding inflation and other factors continues. - FY2023-Q3SoftenedAnnual report
「During the third quarter of the current consolidated cumulative period, the Japanese economy showed signs of a moderate recovery as socioeconomic activity moved further toward normalization, including the reclassification of COVID-19 to Category V under the Infectious Diseases Control Law.」
The reclassification of COVID-19 to Category V under the Infectious Diseases Control Law and the normalization of socioeconomic activity were indicated, weakening perceptions of a direct deterioration in the business environment caused by the infectious disease. However, concerns about another resurgence of infections remain in the Medical Total Solution Business. - FY2023-Q2SoftenedAnnual report
「During the second quarter of the current consolidated cumulative period, the Japanese economy saw signs of stabilization in the COVID-19 infection situation and progress toward the normalization of socioeconomic activity, while」
Stabilization of the infection situation and normalization of socioeconomic activity were indicated, weakening perceptions of a direct deterioration in the business environment caused by the infectious disease. However, concerns about another resurgence of infections remain in the Medical Total Solution Business. - FY2023-Q1WorsenedAnnual report
「During the first quarter of the current consolidated cumulative period, measures to address COVID-19 progressed and efforts were made to balance socioeconomic activity with infection control measures. However, the number of infectious disease patients began to increase again from November 2022.」
While efforts to balance infection control measures with socioeconomic activity progressed, the number of infectious disease patients increased again from November 2022, indicating that infectious disease risks had strengthened once more. - FY2022-Q3RestatedAnnual report
「The medical institutions that are the Group's major customers continue to give top priority to responding to COVID-19, while the strain on the healthcare system remains substantial and various issues persist.」
Medical institutions continue to give top priority to responding to COVID-19, while significant strain and various issues remain in the healthcare system. - FY2022-Q2WorsenedAnnual report
「The medical institutions that are the Group's major customers are giving top priority to responding to COVID-19. The strain on the healthcare delivery system is extremely severe, bringing various issues to light.」
With the COVID-19 pandemic continuing, medical institutions are giving top priority to infectious disease response, and the healthcare delivery system is under extremely severe strain. - FY2022-Q1WorsenedAnnual report
「However, uncertainty remains high, owing to concerns about a rapid increase in infections following the emergence of highly transmissible variants such as Omicron, as well as the risk of accelerating inflation caused by supply chain disruptions and surging energy prices.」
New concerns have emerged over a rapid increase in infections caused by highly transmissible variants such as Omicron, and uncertainty surrounding infectious disease risks continues. - FY2021MaterialisedAnnual report
「The Group has determined that although the spread of COVID-19 has partially disrupted sales activities, including restrictions on in-person sales visits and voluntary restraint on business travel, the impact has been minor and will not materially affect accounting estimates as of the end of the consolidated fiscal year.」
Although restrictions on in-person sales visits and voluntary restraint on business travel affected business activities, the impact on FY2021 performance and accounting estimates was judged to be minor. - FY2021-Q3WorsenedAnnual report
「However, uncertainty remains high amid concerns about renewed spread of infections caused by the emergence of highly transmissible virus variants and declining vaccine effectiveness.」
Although the impact on the year-to-date period's business activities remained limited, uncertainty continued due to highly transmissible variants, declining vaccine effectiveness and the third declaration of a state of emergency. - FY2021-Q2WorsenedAnnual report
「In the healthcare industry to which the group belongs, the number of surgeries and outpatients and inpatients, which fell substantially last spring, has been recovering, but hospital operations remain challenging. As the risk of the healthcare system collapsing has increased amid the renewed spread of infections, many hospitals have been forced to rapidly expand their capacity to respond to COVID-19. In addition, rebuilding healthcare delivery systems in each prefecture, including securing hospital beds and allocating roles among medical institutions according to the severity of patients' symptoms, has become an urgent priority.」
Although the number of surgeries, outpatients and inpatients has been recovering, difficult conditions for hospital operations have continued. The renewed spread of infections has increased the risk of healthcare system collapse, heightening the urgency of expanding hospitals' infection-response capacity and rebuilding healthcare delivery systems. - FY2021-Q1WorsenedAnnual report
「As the risk of the healthcare system collapsing has increased amid the renewed spread of infections, many hospitals have been forced to rapidly expand their capacity to respond to COVID-19. In addition, rebuilding healthcare delivery systems in each prefecture, including securing hospital beds and allocating roles among medical institutions according to the severity of patients' symptoms, has become an urgent priority.」
The renewed spread of infections has increased the risk of healthcare system collapse, and the company stated that many hospitals have been forced to rapidly expand their infection-response capacity. The urgency of rebuilding healthcare delivery systems, including securing hospital beds and allocating roles among medical institutions, has also continued. - FY2020-Q3MaterialisedAnnual report
「Depending on how the spread of COVID-19 develops, it may affect the business activities of the group and its ability to secure earnings. In the healthcare industry to which the group belongs, the spread of COVID-19 has caused the number of surgeries and outpatient and inpatient numbers to decline substantially, and hospital operations remain extremely challenging.」
The infectious disease caused substantial declines in the number of surgeries, outpatients and inpatients in the healthcare industry, and also reduced the number of image interpretations in remote image diagnosis in April and May. The impact on the current fiscal year's results of the Medical Total Solution business was judged to be limited at this point. - FY2020-Q2First statedAnnual report
「The economic slowdown associated with the global spread of COVID-19 is accelerating rapidly, creating an extremely uncertain outlook. Economic activity in Japan has also stagnated due to the impact of COVID-19, resulting in severe conditions. Depending on how the spread of COVID-19 develops, it may affect the business activities of the group and its ability to secure earnings.」
The company described the global spread of the infectious disease, stagnation in economic activity and strain on healthcare delivery systems as conditions that had actually occurred, raising concerns about the impact on hospital operations and the group's business activities and earnings through declines in the number of surgeries, outpatients and inpatients, among other factors.